期刊文献+

抗主要组织相容性相关蛋白MICA/B的单克隆抗体制备及应用 被引量:3

Production and application of monoclonal antibody against major histocompatibility complex class Ⅰ related chain A and B
下载PDF
导出
摘要 目的:制备抗主要组织相容性相关蛋白A/B(MICA/B)的单克隆抗体并对其特异性进行验证。方法:以重组MICA*012蛋白免疫小鼠后将其脾细胞与SP2/0细胞进行融合和筛选得杂交瘤细胞株,并用ELISA对其中9B10细胞株产生的单克隆抗体进行效价检测以及通过Western blot、Luminex、免疫荧光对其特异性进行检测。结果:获得6株杂交瘤细胞株,其中9B10细胞株产生单克隆抗体(m Ab)9B10的最低反应浓度为0.02 ng/μl,且m Ab 9B10可应用于Western blot、Luminex和免疫组化荧光试验对MICA和MICB分子的检测。结论:成功获得可同时检测MICA和MICB表达的单克隆抗体9B10。 Objective: Generation and identification of hybridoma to produce monoclonal antibody against MICA/B. Methods:SP2/0 cells were fused with murine splenocyte immunized with recombinant protein r MICA* 012 to get hybridoma cell lines. The titer of the monoclonal antibody produced by 9B10 cell line was determined by ELISA and its specificity was tested by Western blot,Luminex mutiplex microsphere-based immunoassay and immunofluorescence assay. Results: Six hybridoma cell lines were selected by ELISA screening test. The minimum reaction concentration of m Ab 9B10 was 0. 02 ng/μl,and the specificity of m Ab 9B10 was determinated by Western blot,Luminex mutiplex microsphere-based immunoassay and immunofluorescence. Conclusion: The monoclonal antibody 9B10 was available to apply for the detection of MICA and MICB expression.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2017年第10期1514-1519,共6页 Chinese Journal of Immunology
基金 国家自然科学基金面上项目(81273265 81571562) 湖南省自然科学基金重点项目(2013FJ2005)资助
关键词 MICA MICB 单克隆抗体 杂交瘤细胞 MICA MICB Monoclonal antibody Hybridoma cells
  • 相关文献

参考文献8

二级参考文献137

  • 1张彩,许晓群,张建华,王郡甫,冯进波,张建,田志刚.MHCI类样分子(MICA)在部分肿瘤组织和肿瘤细胞系中的表达及临床意义[J].中国肿瘤临床,2005,32(21):1208-1211. 被引量:13
  • 2Bahram S.MIC genes:from genetics to biology[J].Adv Immunol,2000.76(1):1-60.
  • 3Bahram S,Bresnahan M,Geraghty DE,et al.A second lineage of mammalian major histocompatibility complex class I genes[J].Proc Natl Acad Sci USA,1994,91(14):6259-6263.
  • 4Bahram S,Mizuki N,Inoko H,et al.Nucleotide sequence of the hu-man MHC class I MICA gene[J].Immunogenetics,1996,44:80-81.
  • 5Fodil N,Pellet P,Laloux L,et al.MICA haplotypicdiversity[J].Im-munogenetics,1999,49:557-560.
  • 6Siemens DR,Hu N,Sheikhi AK,et al.Hypoxia Increases Tumor Cell Shedding of MHC Class I Chain Related Molecule:Role of Nitric Oxide[J].Cancer Res,2008,68(12):4746-4753.
  • 7Pende D,Rivera P,Marcenaro S,et al.Major histocompatibility com-plex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes:analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity[J].Cancer Res,2002,62(21):6178-6186.
  • 8Groh V,Rhinehart R,Secrist H,et al.Broad tumor-associated expres-sion and recognition by tumor-derived gamma delta T cells of MICA and MICB[J].Proc Natl Acad Sci U S A.1999,96(12):6879-6884.
  • 9Raulet DH.Roles of t he N KG2D immunoreceptor and it s ligands[J].Nat Rev Immunol,2003,3(10):781-790.
  • 10Zwirner NW,Fuertes MB,Girart MV,et al.Cytokine-driven regula-tion NK cell functions in tumor immunity:Role of the MICA2-NKG2D system[J].Cytokine Growth Factor Reviews,2007,18(122):159-170.

共引文献21

同被引文献19

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部